Combinostics develops AI-powered tools for early detection, diagnosis, and management of neurological disorders. Their cNeuro® platform combines imaging data, biomarkers, and clinical information to support personalized care and disease progression prediction, focusing on conditions like dementia and Alzheimer’s.